ProfileGDS4132 / 1560524_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 40% 37% 37% 35% 44% 36% 33% 30% 29% 34% 27% 24% 29% 30% 32% 33% 26% 30% 32% 29% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101105.31840
GSM201543Muscle PCOS pioglitazone 12187.436137
GSM201544Muscle PCOS pioglitazone 16196.30637
GSM201545Muscle PCOS pioglitazone 20195.810635
GSM201829Muscle PCOS pioglitazone 231121.77144
GSM201830Muscle PCOS pioglitazon 25194.229536
GSM201831Muscle PCOS pioglitazone 27180.769333
GSM201832Muscle PCOS pioglitazone 3173.607930
GSM201833Muscle PCOS pioglitazone 4167.383429
GSM201834Muscle PCOS pioglitazone 8183.844334
GSM201835Muscle PCOS after pioglitazone 10253.064727
GSM201836Muscle PCOS after pioglitazone 12247.19124
GSM201837Muscle PCOS after pioglitazone 16257.763629
GSM201838Muscle PCOS after pioglitazone 20266.429930
GSM201839Muscle PCOS after pioglitazone 23274.197732
GSM201840Muscle PCOS after pioglitazone 25279.319333
GSM201841Muscle PCOS after pioglitazone 27249.087826
GSM201842Muscle PCOS after pioglitazone 3258.697930
GSM201843Muscle PCOS after pioglitazone 4276.451632
GSM201844Muscle PCOS after pioglitazone 8264.83729